Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Monday, July 9th, Zacks reports. Stockholders of record on Friday, August 31st will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, September 17th. This represents a $0.64 annualized dividend and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, August 30th.

Mesa Laboratories has increased its dividend by an average of 1.6% annually over the last three years. Mesa Laboratories has a payout ratio of 9.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Mesa Laboratories to earn $8.19 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.8%.

MLAB traded down $4.42 on Friday, reaching $204.28. The company had a trading volume of 14,139 shares, compared to its average volume of 22,546. Mesa Laboratories has a fifty-two week low of $122.35 and a fifty-two week high of $224.95. The firm has a market cap of $806.27 million, a P/E ratio of 33.06 and a beta of 0.26. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.55 and a current ratio of 2.10.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Tuesday, July 31st. The medical instruments supplier reported $1.06 EPS for the quarter, beating the Zacks’ consensus estimate of $0.79 by $0.27. Mesa Laboratories had a negative net margin of 0.25% and a positive return on equity of 15.92%. The business had revenue of $25.14 million for the quarter. equities analysts forecast that Mesa Laboratories will post 7.09 earnings per share for the current year.

A number of research analysts recently commented on the stock. ValuEngine lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Tuesday, May 22nd. TheStreet lowered shares of Mesa Laboratories from a “b-” rating to a “c” rating in a research note on Tuesday. BidaskClub lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Friday, May 25th. Finally, Zacks Investment Research upgraded shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $248.00 price target on the stock in a research note on Wednesday, July 11th.

In other Mesa Laboratories news, Director Robert V. Dwyer sold 5,000 shares of the stock in a transaction that occurred on Wednesday, June 20th. The shares were sold at an average price of $210.03, for a total transaction of $1,050,150.00. Following the transaction, the director now owns 63,421 shares in the company, valued at approximately $13,320,312.63. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director H Stuart Campbell sold 989 shares of the stock in a transaction that occurred on Monday, June 11th. The stock was sold at an average price of $191.17, for a total transaction of $189,067.13. Following the transaction, the director now owns 41,527 shares in the company, valued at approximately $7,938,716.59. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,989 shares of company stock worth $3,806,957. 15.70% of the stock is owned by company insiders.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Further Reading: What is the NASDAQ Stock Market?

Dividend History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.